Inventor · disambiguated record
Ling Liu
Also filed as: LIU LING · LIU LING SUM
19 granted patents·6 pending applications·193 citations·filing 2001–2024
93Inventor score
Top patents by PatentIndex Score
25 records- 0195US7838638B2Anti-IL-17 antibodiesLILLY CO ELI·Filed 2006·Granted Nov 23, 2010·81 cites·4 claims
- 0293US8110191B2Anti-IL-17 antibodiesALLAN BARRETT·Filed 2010·Granted Feb 7, 2012·44 cites·3 claims
- 0392US8043618B2Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatmentIMCLONE LLC·Filed 2009·Granted Oct 25, 2011·14 cites·6 claims
- 0489US10934362B2Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereofAMGEN INC·Filed 2015·Granted Mar 2, 2021·5 cites·43 claims
- 0588US8217148B2c-Met antibodiesDAVIES JULIAN·Filed 2009·Granted Jul 10, 2012·12 cites·19 claims
- 0687US8398974B2c-Met antibodiesDAVIES JULIAN·Filed 2012·Granted Mar 19, 2013·11 cites·20 claims
- 0783US9201074B2Anti-c-Met antibodiesDAVIES JULIAN·Filed 2012·Granted Dec 1, 2015·4 cites·21 claims
- 0882US9328173B2Multifunctional antibodies binding to EGFR and METLILLY CO ELI·Filed 2014·Granted May 3, 2016·7 cites·8 claims
- 0979US9260531B2Anti-c-met antibodiesLILLY CO ELI·Filed 2013·Granted Feb 16, 2016·7 cites·24 claims
- 1079US8182815B2Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatmentSUN HAIJUN·Filed 2011·Granted May 22, 2012·2 cites·5 claims
- 1176US12280070B2Drugs for prevention or treatment of sepsisUNIV SOUTHEAST·Filed 2024·Granted Apr 22, 2025·0 cites·3 claims
- 1276US9580499B2VEGFR2/Ang2 compoundsLILLY CO ELI·Filed 2015·Granted Feb 28, 2017·2 cites·10 claims
- 1371US10662189B2PDE4 inhibitorSHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD·Filed 2017·Granted May 26, 2020·1 cites·31 claims
- 1470US2024384343A1Graphene oxide-based fluorescent sensor for biomolecular detectionUNIV CITY HONG KONG·Filed 2024·Application pending·0 cites
- 1565US7101539B2Use of LP82 to treat hematopoietic disordersLILLY CO ELI·Filed 2002·Granted Sep 5, 2006·3 cites·13 claims
- 1664US2023122281A1TNA-BASED PROBE FOR DETECTING AND IMAGING A TARGET miRNA IN LIVING CELLSUNIV CITY HONG KONG·Filed 2022·Application pending·0 cites
- 1762US11919964B2Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereofAMGEN INC·Filed 2020·Granted Mar 5, 2024·0 cites·33 claims
- 1855US12364667B2Anti-tumor platinum-based drug mineralized protein nanoparticle, preparation method therefor and use thereofUNIV SOOCHOW·Filed 2021·Granted Jul 22, 2025·0 cites·7 claims
- 1954US11167039B2MET antibody drug conjugatesLILLY CO ELI·Filed 2017·Granted Nov 9, 2021·0 cites·13 claims
- 2050US2005233954A1Use of resistin to treat hematopoietic disordersLILLY CO ELI·Filed 2003·Application pending·0 cites
- 2146US11938187B2Methods and compositions for synthesis of two-photon cleavable phosphoramidite molecules for oligonucleotide conjugationUNIV CITY HONG KONG·Filed 2021·Granted Mar 26, 2024·0 cites·3 claims
- 2245US2017121411A1VEGFR2/Ang2 CompoundsLILLY CO ELI·Filed 2017·Application pending·0 cites
- 2345US2006083713A1Methods of using a human il-17 related polypeptide to treat diseaseLILLY CO ELI·Filed 2001·Application pending·0 cites
- 2444US2005158718A1Diagnostic and therapeutic uses of SUFU geneFiled 2003·Application pending·0 cites
- 2535US9670284B2Therapeutic uses for VEGFR1 antibodiesLILLY CO ELI·Filed 2014·Granted Jun 6, 2017·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Ling Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →